Clinical Experience with a New Cardioverter Defibrillator Capable of Biphasic Waveform Pulse and Enhanced Data Storage: Results of a Prospective Multicenter Study

Pacing and Clinical Electrophysiology

Volumn 17, Issue 7, 1994, Pages 1243-1255

  NEUZNER, JOERG ^a  

^a KERCKHOFF HEART CENTER   (Germany)

Author keywords

biphasic defibrillation waveform; implantable cardioverter defibrillator; nonthoracotomy systems; stored electrograms; sudden cardiac death

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIOVERSION; CONGESTIVE CARDIOMYOPATHY; DEFIBRILLATION; DEFIBRILLATOR; FEMALE; HEART FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; SUDDEN DEATH; SUPRAVENTRICULAR TACHYCARDIA;

ADOLESCENT; ADULT; AGED; ARRHYTHMIA; CARDIAC PACING, ARTIFICIAL; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; EQUIPMENT DESIGN; EQUIPMENT FAILURE; FEMALE; FOLLOW-UP STUDIES; HUMAN; INFORMATION STORAGE AND RETRIEVAL; INTRAOPERATIVE CARE; MALE; MIDDLE AGE; PROSPECTIVE STUDIES; RECURRENCE; SURVIVAL RATE; TACHYCARDIA, VENTRICULAR; THORACOTOMY; VENTRICULAR FIBRILLATION;

EID: 0027978501     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.1994.tb01491.x     Document Type: Article

References (46)

1. Termination of malignant ventricular arrhythmics with an implantable automatic defibrillator in human beings
2. Clinical treatment of life‐threatening ventricular tachyarrhythmias with the automatic implantable defibrillator
3. Long‐term outcome with the automatic implantable cardioverter/defibrillator
4. Role of implantable cardioverter defibrillator therapy in the management of high‐risk patients
5. The automatic implantable cardioverter/defibrillator: Efficacy, complications and survival in patients with malignant ventricular arrhythmias
6. Long‐term multicenter experience with a second generation implantable pacemaker‐defibrillator in patients with malignant ventricular arrbythmia
7. ICD clinical update: First decade, initial 10,000 patients
8. Mortality in patients with implanted automatic defibrillators
9. Clinical experience, complications and survival in 70 patients with the automatic implantable cardioverter/defibrillator
10. Patient survival comparison in three generations of automatic implantable cardioverter defibrillators; Review of 12 years, 25,000 patients
11. Results and realistic expectations with transvenous lead systems
12. the PCD Investigators Defibrillation thresholds and perioperative mortality associated with endocardial and epicardial lead systems
13. Automatic implantable cardioverter defibriilator: Surgical approaches for implantation
14. Clinical results with nonthoracotomy ICD systems
15. Operative mortality with implantation of the automatic cardioverter‐defibrlllator
16. Do patients with an implantable defibrillator live longer
17. Improved low energy defibrillation efficacy in man with the use of a biphasic truncated exponential waveform
18. Comparative efficacy of monophasic and biphasic truncated exponential shocks for nonthoracotomy internal defibrillation in dogs
19. A prospective randomized evaluation of biphasic versus monophasic pulses on defibrillation efficacy in humans
20. Comparison of internal defibrillation thresholds for monophasic and double and single capacitor biphasic waveforms
21. Improved internal defibrillation efficacy with biphasic waveform
22. Comparison of biphasic and monophasic shocks using a nonthoracotomy lead system
23. Termination of ventricular fibrillation in dogs by depolarizing a critical amount of myocardium
24. Decreased defibrillation induced dysfunction with biphasic rectangular waveforms
25. Improved cardiac cell excitation with symmetrical biphasic defibrillator waveforms
26. Ventricular defibrillation using biphasic waveforms: The importance of phasic duration
27. Electrode system influence on biphasic waveform defibrillation efficacy in humans
28. Relation of the intraoperative defibrillation threshold to successful postoperative defibrillation with an automatic implantable cardioverter defibrillator
29. Defibrillation threshold: Clinical utility and therapeutic implications
30. Feasibility and effectiveness of low‐energy catheter defibrillation in man
31. Comparative efficacy of transvenous cardioversion and pacing in patients with sustained ventricular tachycardia: A prospective, randomized crossover study
32. Evaluation of electrode polarity on defibrillation efficacy
33. The automatic implantable cardioverter‐defibrillator: Effect of patch polarity on defibrillation threshold
34. Mechanism of death in patients with the automatic implantable cardioverter defibrillator
35. Sudden bradyarrhythmic death in patients with the impiantable cardioverter‐defibrillator: Report of two cases
36. Analysis of deaths in patients with an implantable cardiovertor dfifibrillator
37. Clinical interactions between pacemakers and automatic implantable cardioverter defibrillator
38. Clinical performance of the implantable cardioverter defibrillator: Eloctrocardiographic documentation of 101 spontaneous discharges
39. Accuracy of rhythm classification using a data log system in implantable cardioverter defibrillator
40. Value of ventricular eloctrogram recordings in the diagnosis of arrhythmias precipitating electrical device shock therapy
41. Importance of abortive shock capability with electrogram storage in cardioverter‐defibrillator device
42. Implantable cardioverter defibrillator: Ventritex Cadence
43. Elektrogramme als dianostische Hilfe bei ICD's—Vergleich von Sensing und Defibrillationselektroden
44. Use of bipolar recordings from patch‐patch and rate sensing leads to distinguish ventricular tachycardia from supraventricular rhythms in patients with implantable cardioverter defibrillators
45. Gespeicherte intrakardiale Elektrogramme: Genauigkeit der Arrhythmieklassifikation bei Patienten mit Kardioverter/Defibrillator‐System
46. Sudden death mortality in implantable cardioverter defibrillator patients